Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells-Reference-Cited by-同舟云学术

Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells

Published:2012-05 Issue:1 Volume:160 Page:88-95
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Unger Wendy W.J.,van Beelen Astrid J.,Bruijns Sven C.,Joshi Medha,Fehres Cynthia M.,van Bloois Louis,Verstege Marleen I.,Ambrosini Martino,Kalay Hakan,Nazmi Kamran,Bolscher Jan G.,Hooijberg Erik,de Gruijl Tanja D.,Storm Gert,van Kooyk Yvette

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Innate immune recognition;Janeway;Annu. Rev. Immunol.,2002

2. Dendritic cells: specialized and regulated antigen processing machines;Mellman;Cell,2001

3. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo;Carbone;J. Exp. Med.,1990

4. ‘Dressed for success’ C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells;Unger;Curr. Opin. Immunol.,2011

5. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination;Bonifaz;J. Exp. Med.,2004

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FORMULATION AND EVALUATION OF ETODOLAC AND TRIAMCINOLONE ACETONIDE LOADED NANO LIPID CARRIER GELS FOR THE THERAPEUTIC MANAGEMENT OF OSTEOARTHRITIS PAIN THROUGH TOPICAL ADMINISTRATION: A COMPARATIVE STUDY;International Journal of Applied Pharmaceutics;2024-09-07

2. Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity;International Journal of Pharmaceutics;2024-07

3. The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan;Carbohydrate Polymers;2024-05

4. Secondary Sites of the C‐type Lectin‐Like Fold;Chemistry – A European Journal;2024-04-30

5. Smart liposome technology for drug delivery of bioactives;Progress and Prospect of Nanocarriers;2024